Medicare Enrolled
Dr. Ginger Kubala, MD
Family Medicine · Cincinnati, OH
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kubala from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kubala?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kubala
Dr. Ginger Kubala is a family medicine specialist in Cincinnati, OH, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kubala performed 1,256 Medicare services across 726 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kubala received a total of $16,731 from 71 pharmaceutical and/or device companies across 1154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kubala is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 16% volume in OH
$16,731 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,256
Medicare services
Top 16% in OH for family medicine
726
Unique beneficiaries
$59
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~66 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
547 | $54 | $190 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
142 | $60 | $177 |
| Advance care planning consultation, first 30 min A session focused on discussing and documenting future healthcare preferences and goals. This service covers the initial 30 minutes of the planning discussion. |
129 | $37 | $62 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
124 | $121 | $199 |
| Urinalysis, manual A manual laboratory examination of a urine sample to check for various substances and cells. |
65 | $3 | $17 |
| Hospital discharge day management, 30 minutes or less This service covers the final day of hospital care when the patient is being discharged. It includes coordination of care and instructions for the patient within a time frame of 30 minutes or less. |
34 | $62 | $253 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
33 | $70 | $75 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
33 | $28 | $34 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
30 | $97 | $311 |
| Routine 12-lead electrocardiogram (ECG) A test that records the electrical activity of the heart using at least 12 leads to produce a tracing. |
27 | $4 | $112 |
| Transitional care management services, moderate complexity Services provided to coordinate care during the transition from an inpatient or other facility setting back to the community. This includes follow-up and management of a health problem of at least moderate complexity. |
25 | $148 | $200 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
23 | $7 | $28 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
17 | $74 | $235 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
15 | $18 | $60 |
| Initial preventive physical examination, new Medicare beneficiary A comprehensive preventive health visit for new Medicare beneficiaries during their first 12 months of enrollment. The service is conducted as a face-to-face visit and is limited to preventive care. |
12 | $158 | $229 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$16,731
Total received (2018-2024)
Avg $2,390/year across 7 years
Top 2% in OH for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
71
Companies
1,154
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,530 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$201 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,332
2023
$3,346
2022
$2,852
2021
$2,952
2020
$1,519
2019
$1,398
2018
$1,331
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$552
Novo Nordisk Inc
$427
ABBVIE INC.
$424
Lilly USA, LLC
$290
Boehringer Ingelheim Pharmaceuticals, Inc.
$252
PFIZER INC.
$215
Novartis Pharmaceuticals Corporation
$152
GlaxoSmithKline, LLC.
$142
Astellas Pharma US Inc
$126
Bayer Healthcare Pharmaceuticals Inc.
$102
Sumitomo Pharma America, Inc.
$85
Amgen Inc.
$83
Exact Sciences Corporation
$66
Axsome Therapeutics, Inc.
$66
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$56
SHIELD THERAPEUTICS INC
$54
Phathom Pharmaceuticals, Inc.
$45
Xeris Pharmaceuticals, Inc.
$41
Merck Sharp & Dohme LLC
$35
Esperion Therapeutics, Inc.
$25
Lexicon Pharmaceuticals, Inc.
$24
Otsuka America Pharmaceutical, Inc.
$23
Dexcom, Inc.
$18
IDORSIA PHARMACEUTICALS US INC
$16
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 42.1% of 2024 payments
All-time payments by company (2018-2024) ›
Novo Nordisk Inc
$2,111
AstraZeneca Pharmaceuticals LP
$1,950
ABBVIE INC.
$1,380
Boehringer Ingelheim Pharmaceuticals, Inc.
$916
Lilly USA, LLC
$872
GlaxoSmithKline, LLC.
$818
PFIZER INC.
$630
Amarin Pharma Inc.
$482
AbbVie Inc.
$465
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$448
Astellas Pharma US Inc
$443
Novartis Pharmaceuticals Corporation
$441
Janssen Pharmaceuticals, Inc
$398
Amgen Inc.
$350
Merck Sharp & Dohme Corporation
$345
Teva Pharmaceuticals USA, Inc.
$307
Biohaven Pharmaceuticals, Inc.
$294
Esperion Therapeutics, Inc.
$263
MannKind Corporation
$257
Bayer Healthcare Pharmaceuticals Inc.
$245
SANOFI-AVENTIS U.S. LLC
$229
Sumitomo Pharma America, Inc.
$216
Allergan, Inc.
$216
Biohaven Pharmaceutical Holding Company Ltd.
$197
Exact Sciences Corporation
$187
Mannkind Corporation
$174
Bayer HealthCare Pharmaceuticals Inc.
$153
Abbott Laboratories
$141
Merck Sharp & Dohme LLC
$116
Phathom Pharmaceuticals, Inc.
$116
Allergan Inc.
$112
Sunovion Pharmaceuticals Inc.
$108
Xeris Pharmaceuticals, Inc.
$97
Eisai Inc.
$91
Genentech USA, Inc.
$90
Takeda Pharmaceuticals U.S.A., Inc.
$82
Axsome Therapeutics, Inc.
$66
AbbVie, Inc.
$59
SHIELD THERAPEUTICS INC
$54
Dexcom, Inc.
$51
DEXCOM, INC.
$46
Corium, LLC
$43
Ironwood Pharmaceuticals, Inc
$42
Horizon Therapeutics plc
$40
IDORSIA PHARMACEUTICALS US INC
$40
Supernus Pharmaceuticals, Inc.
$38
Otsuka America Pharmaceutical, Inc.
$37
Medtronic, Inc.
$34
Shield Therapeutics Inc
$34
Hikma Pharmaceuticals USA
$34
SANOFI PASTEUR INC.
$32
ARBOR PHARMACEUTICALS, INC.
$31
BOSTON SCIENTIFIC CORPORATION
$29
Kowa Pharmaceuticals America, Inc.
$27
Lexicon Pharmaceuticals, Inc.
$24
Clarus Therapeutics Inc.
$24
Medtronic Vascular, Inc.
$22
Phadia US Inc.
$20
Antares Pharma, Inc.
$17
Circassia Pharmaceuticals Inc
$13
E.R. Squibb & Sons, L.L.C.
$13
Avanir Pharmaceuticals, Inc.
$13
Aytu BioScience, Inc
$13
Tris Pharma Inc
$13
Nabriva Therapeutics, plc
$13
Hologic, LLC
$12
Currax Pharmaceuticals LLC
$12
Sanofi Pasteur Inc.
$12
Eyevance Pharmaceuticals LLC
$12
Noden Pharma USA Inc
$11
Horizon Pharma plc
$11
Top 3 companies account for 32.5% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADACEL · ADVAIR · AFREZZA · AIRSUPRA · AJOVY · ANORO · ANORO ELLIPTA · APTIMA · AREXVY · AUSTEDO · AZSTARYS · Adlarity · Aimovig · AirDuo Digihaler · Auvelity · BELSOMRA · BREO · BREZTRI · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · CHANTIX · COMIRNATY · CONTRAVE · CREON · ClosureFast · Cologuard Collection Kit · Creon · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FASENRA · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT NORTHERN HEMISPHERE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre 2 · GARDASIL · GATTEX · GEMTESA · GENERAL PAIN MANAGEMENT · GVOKE HYPOPEN · GVOKE PFS · INVOKANA · ImmunoCAP · JANUVIA · JARDIANCE · JATENZO · KRYSTEXXA · Kerendia · LEQVIO · LINZESS · Linzess · Livalo · MOUNJARO · MYRBETRIQ · Mitigare · Myrbetriq · NEXLETOL · NEXLIZET · NUEDEXTA · NURTEC ODT · Natesto · Otezla · Otrexup · Ozempic · PAXLOVID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · Prolia · QELBREE · QULIPTA · QUVIVIQ · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Saxenda · Sivextro · Synthroid · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Tobradex ST · Tresiba · UBRELVY · VIBERZI · VIIBRYD · VOQUEZNA · VRAYLAR · VYNDAMAX · VYVANSE · Vascepa · Veozah · Victoza · WATCHMAN · Wegovy · XARELTO · XIFAXAN · XIGDUO · Xofluza · Xultophy 100/3.6
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 2% for family medicine in OH.
Geographic Context
Family medicine physicians within 10 mi
831
Per 100K population
100.4
County median income
$70,816
Nearest hospital
BETHESDA NORTH
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kubala is a clinical cardiology specialist, with above-average Medicare volume (top 16% in OH), with low-engagement industry engagement in the top 2% of OH peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kubala experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Kubala performed 547 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kubala receive payments from pharmaceutical companies?
Yes. Dr. Kubala received a total of $16,731 from 71 companies across 1,154 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kubala's costs compare to other family medicine physicians in Cincinnati?
Dr. Kubala's average Medicare payment per service is $59. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kubala) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Cincinnati
Browse family medicine physicians in Cincinnati ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in OH
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in OH
Which OH family medicine physicians receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology